Jefferies Maintains DAIICHI SANKYO COMPANY LIMITED(DSKYF.US) With Buy Rating, Cuts Target Price to $40.58

Moomoo NewsApr 2 11:31 ET · Ratings

DAIICHI SANKYO COMPANY LIMITED To Go Ex-Dividend On March 28th, 2025 With 0.264 USD Dividend Per Share

Moomoo NewsMar 26 21:00 ET

Daiichi Sankyo Company, Limited (DSKYF) Q3 2024 Earnings Call Transcript Summary

moomoo AIJan 31 22:23 ET · Conference Call

Daiichi Sankyo Sees ENHERTU Sales Reaching ¥539.9B in FY2024 Amid Oncology Momentum

Seeking AlphaJan 31 22:21 ET

Daiichi Sankyo Reports 9M Results

Seeking AlphaJan 31 10:56 ET

AstraZeneca, Daiichi Win EU Backing for Breast Cancer Drug Dato-DXd

Seeking AlphaJan 31 09:08 ET

J.P. Morgan Maintains DAIICHI SANKYO COMPANY LIMITED(DSKYF.US) With Buy Rating, Cuts Target Price to $38.8

Moomoo NewsJan 29 07:34 ET · Ratings

FDA Approves AstraZeneca, Daiichi Sankyo's Enhertu For Certain Type Of Breast Cancer Patients

BenzingaJan 28 10:29 ET

Bernstein Maintains DAIICHI SANKYO COMPANY LIMITED(DSKYF.US) With Buy Rating, Cuts Target Price to $41.13

Moomoo NewsJan 27 07:34 ET · Ratings

FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients

BenzingaJan 21 12:54 ET

Bernstein Maintains DAIICHI SANKYO COMPANY LIMITED(DSKYF.US) With Buy Rating, Raises Target Price to $41.1

Moomoo NewsJan 20 08:31 ET · Ratings

FDA Grants Priority Review to Daiichi Sankyo and AstraZeneca's Datopotamab Deruxtecan for Advanced Lung Cancer Treatment

BenzingaJan 13 02:14 ET

Here Are Morgan Stanley's Key Oncology Catalysts for 2025

Seeking AlphaDec 28, 2024 10:31 ET

Daiichi Sankyo Gets Japanese Approval for Datroway

Seeking AlphaDec 27, 2024 10:52 ET

J.P. Morgan Maintains DAIICHI SANKYO COMPANY LIMITED(DSKYF.US) With Buy Rating, Cuts Target Price to $44.55

Moomoo NewsDec 23, 2024 14:31 ET · Ratings

Citi Maintains DAIICHI SANKYO COMPANY LIMITED(DSKYF.US) With Buy Rating, Cuts Target Price to $40.73

Moomoo NewsDec 23, 2024 12:32 ET · Ratings

After Lung Cancer Approval, AstraZeneca's Imfinzi Goes Under FDA Priority Review For Bladder Cancer

BenzingaDec 6, 2024 09:03 ET

Morgan Stanley Initiates DAIICHI SANKYO COMPANY LIMITED(DSKYF.US) With Buy Rating, Announces Target Price $36.41

Moomoo NewsNov 25, 2024 03:33 ET · Ratings

AstraZeneca Raised to Neutral at UBS Despite China Headwinds

Seeking AlphaNov 20, 2024 08:41 ET

AstraZeneca, Daiichi File for FDA Accelerated Approval of Dato-DXd

Seeking AlphaNov 12, 2024 13:28 ET